NYSE: ATIP - ATI Physical Therapy, Inc.

Yield per half year: -56.75%
Sector: Healthcare

ATI Physical Therapy, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 57.86 -100% -21.8 -100%
P/S 0.0376 4.07 -99.08%
P/BV 0.2111 9.4 -97.75%
P/FCF -1.09 46.57 -102.35%
Ev/Ebitda 11.66 17.55 -33.54%
Ev/S 1.06 4.37 -75.78%
Ev/FCF -24.91 54.59 -145.64%
E/P -2.15 0.2164 -1093.41%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
3/10
9.07 20.15 -54.98% -3.89 -333.2%
ROE -58.46 -80.86 -27.7%
ROA -6.06 6.71 -190.27%
ROIC -73.63 15.68 -569.68%
ROS -9.98 10.55 -194.55%
ROCE -17.61 18.05 -197.53%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
8.9 2.82 216.19% 7.22 +23.23%
Nеt Debt/Ebitda 11.25 3.64 209.32%
Debt/Ratio 0.4903 0.261 87.85%
Debt/Equity 4.56 4.49 1.55%
Debt/Net Income -8.09 6.45 -225.38%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.29 -100% 0 0%
Number of years of dividend growth 0 6.33 -100%
DSI 0 0.7376 -100%
Average dividend growth 0 -3.12 -100%
Average percentage for 5 years 0 1.29 -100%
Average percentage for payments 0 77.61 -100%
Difference from average difference in sector -1.29

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-10.95 362.86 -103.02%
Growth impulse Ebitda in 5 years -63.98 373.75 -117.12%
Growth impulse Net Income in 5 years -797.95 454.84 -275.44%
Growth impulse FCF in 5 years -524.11 306.17 -271.18%
Growth impulse EPS in 5 years -33874.5 455.99 -7528.78%
IP Score
2.27/10

Similar companies

Evolent Health

Teva Pharmaceutical Industries

Varian Medical

Mallinckrodt public limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription